Create Account | Sign In: Author or Forum

News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
Category: AIDS | Monthly Briefing

Back to Journal Articles

April 2009 Briefing - HIV & AIDS

Last Updated: May 01, 2009.


Share |

Comments: (0)




Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for April 2009. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

New Web-based Information Source to Support UK Clinicians

THURSDAY, April 30 (HealthDay News) -- The United Kingdom's National Institute for Health and Clinical Excellence (NICE) has announced the launch of NHS Evidence, a Web-based evidence resource for clinicians, public health professionals of the National Health Service, and others involved in making patient care decisions. The announcement came in the April 30 issue of The Lancet.

NICE home page
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

NEJM Commends New Conflict of Interest Proposal

THURSDAY, April 30 (HealthDay News) -- A new proposal to control conflict of interest is notable for its breadth and variety of recommended solutions, according to a Perspective article published online April 29 in the New England Journal of Medicine.

Full Text

FDA Requires OTC Pain Relievers to Display Warnings

WEDNESDAY, April 29 (HealthDay News) -- Popular over-the-counter (OTC) pain relievers and fever medications containing acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs) will be required to display prominent warnings about the risks of liver damage and internal bleeding, under a new rule announced April 28 by the U.S. Food and Drug Administration (FDA).

More Information

Pharmacist Involvement May Decrease Medication Errors

TUESDAY, April 28 (HealthDay News) -- Adding a pharmacist to health care teams may significantly decrease patients' risk of adverse drug events and medication errors, according to a report published in the April 27 issue of the Archives of Internal Medicine. A second study indicates that an interdisciplinary medication reconciliation intervention can also reduce unintentional medication discrepancies with potential for harm.

Abstract - Murray
Full Text (subscription or payment may be required)
Abstract - Schnipper
Full Text (subscription or payment may be required)

Steep Copayments Increase Risk of Non-Adherence

TUESDAY, April 28 (HealthDay News) -- In patients who are newly diagnosed with a chronic disease, higher out-of-pocket costs for medications are associated with an increased likelihood of non-treatment, according to a study published in the April 27 issue of the Archives of Internal Medicine.

Full Text (subscription or payment may be required)

Having Health Insurance May Not Improve Mortality Risk

THURSDAY, April 23 (HealthDay News) -- People without health insurance have about the same mortality rate as people with health insurance, according to an observational study published online April 21 in Health Services Research.

Full Text (subscription or payment may be required)

Stretches Without Health Insurance More Common

WEDNESDAY, April 22 (HealthDay News) -- Periods of uninsurance have become more common in recent decades, particularly among those with less education, according to research published in the April 23 issue of the New England Journal of Medicine.

Full Text

Continuity of Care Declining for Medicare Beneficiaries

TUESDAY, April 21 (HealthDay News) -- Medicare beneficiaries in the hospital in 2006 were much less likely to be seen there by a familiar physician than those in the hospital a decade earlier, according to a study reported in the April 22/29 issue of the Journal of the American Medical Association.

Full Text (subscription or payment may be required)

Drug-Resistant TB Remains a Worldwide Threat

THURSDAY, April 16 (HealthDay News) -- Drug-resistant tuberculosis (TB) remains a serious worldwide problem with the median prevalence of multidrug-resistant strains of TB as high as one in five new cases in some hot spots, according to the results of a survey by the World Health Organization reported in the April 16 online edition of The Lancet.

Full Text (subscription or payment may be required)

Injecting-Drug Users Still Put Themselves at Risk for HIV

FRIDAY, April 10 (HealthDay News) -- Injecting-drug users accounted for 6,600 (12 percent) of the new cases of HIV detected in the United States in 2006, and many report engaging in HIV-associated behaviors, according to a report published in the April 10 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

More Information

Financial Rewards for Healthy Behavior Can Be Effective

FRIDAY, April 10 (HealthDay News) -- Although paying people to engage in healthy behaviors or successfully tackle unhealthy ones can be effective, it may carry unintended consequences, according to an editorial published online April 9 in BMJ.


Minimum Threshold Suggested for HIV Antiretroviral Therapy

THURSDAY, April 9 (HealthDay News) -- In AIDS-free HIV-infected patients, a CD4 cell count of 350 should be the minimum threshold for initiation of antiretroviral therapy, according to a study published online April 9 in The Lancet.

Full Text (subscription or payment may be required)

Early Antiretroviral Therapy Benefits HIV-Positive Patients

THURSDAY, April 2 (HealthDay News) -- In asymptomatic HIV-positive patients, early initiation of antiretroviral therapy significantly improves survival compared to deferred initiation, according to a report published online April 1 in the New England Journal of Medicine.

Full Text

Electronic Prescribing Online-Learning Tools Launched

THURSDAY, April 2 (HealthDay News) -- U.S. physicians will be able to better evaluate electronic prescribing systems thanks to a new online learning center on ePrescribing launched April 1 by the American Medical Association.

More Information

Changes Needed in New-Drug Evaluation Process

WEDNESDAY, April 1 (HealthDay News) -- The evaluation process for new drugs is overdue for an overhaul, which could provide benefits for the public and the pharmaceutical industry, according to a point-counterpoint commentary published online March 31 in BMJ.

Abstract - Garattini
Full Text (subscription or payment may be required)
Abstract - Tremblay
Full Text (subscription or payment may be required)

New Health Program Leads to Questions in the UK

WEDNESDAY, April 1 (HealthDay News) -- A new British program to improve patient choices and competition in the health care marketplace may lead to excess capacity in some areas and instability in others, according to a commentary published online March 31 in BMJ.

Full Text (subscription or payment may be required)

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Previous: April 2009 Briefing - Gastroenterology Next: April 2009 Briefing - Infectious Disease

Reader comments on this article are listed below. Review our comments policy.

Submit your opinion:





Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application


 advertisement.gif (61x7 -- 0 bytes)



Useful Sites
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2015
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.